Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引：0
|
作者：
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构：
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [1] Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer
    Goya, Hiroki
    Kuraishi, Hiroshi
    Koyama, Shigeru
    Ichiyama, Takashi
    Yoshiike, Fumiaki
    Hirai, Kazuya
    Agatsuma, Toshihiko
    Tateishi, Kazunari
    Kanda, Shintaro
    Yamamoto, Hiroshi
    Kubo, Keishi
    Koizumi, Tomonobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 691 - 697
  • [2] A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer
    Ikemura, Shinnosuke
    Naoki, Katsuhiko
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Yoda, Satoshi
    Terai, Hideki
    Sato, Takashi
    Ishioka, Kota
    Arai, Daisuke
    Ohgino, Keiko
    Kamata, Hirofumi
    Miyata, Jun
    Kabata, Hiroki
    Betsuyaku, Tomoko
    Soejima, Kenzo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 356 - 361
  • [3] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Satoshi Yoda
    Kenzo Soejima
    Hiroyuki Yasuda
    Katsuhiko Naoki
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Ryosuke Satomi
    Sohei Nakayama
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Maiko Morosawa
    Koichiro Asano
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 717 - 722
  • [4] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Naoki, Katsuhiko
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Satomi, Ryosuke
    Nakayama, Sohei
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Morosawa, Maiko
    Asano, Koichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 717 - 722
  • [5] Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer
    Shiroyama, Takayuki
    Komuta, Kiyoshi
    Imamura, Fumio
    Hirashima, Tomonori
    Kijima, Takashi
    Tachibana, Isao
    Kawase, Ichiro
    LUNG CANCER, 2011, 74 (01) : 85 - 88
  • [6] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Oizumi, Satoshi
    Yamazaki, Koichi
    Yokouchi, Hiroshi
    Konishi, Jun
    Hommura, Fumihiro
    Kojima, Tetsuya
    Isobe, Hiroshi
    Nishimura, Masaharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 125 - 129
  • [7] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Satoshi Oizumi
    Koichi Yamazaki
    Hiroshi Yokouchi
    Jun Konishi
    Fumihiro Hommura
    Tetsuya Kojima
    Hiroshi Isobe
    Masaharu Nishimura
    International Journal of Clinical Oncology, 2009, 14 : 125 - 129
  • [8] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
  • [9] Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer:: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
    Vázquez, S
    Grande, C
    Amenedo, M
    Fírvida, JL
    Lázaro, M
    Alonso, G
    Curiel, T
    Huidobro, G
    Mel, JR
    Ramos, M
    ANTI-CANCER DRUGS, 2004, 15 (05) : 489 - 494
  • [10] A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)
    Nishino, Kazumi
    Imamura, Fumio
    Kumagai, Toru
    Katakami, Nobuyuki
    Hata, Akito
    Okuda, Chiyuki
    Urata, Yoshiko
    Hattori, Yosihihiro
    Tachihara, Motoko
    Yokota, Souichirou
    Nishimura, Takashi
    Kaneda, Toshihiko
    Satouchi, Miyako
    Morita, Satoshi
    Negoro, Shunichi
    LUNG CANCER, 2015, 89 (02) : 146 - 153
12345